ArticleAddictive behaviors2026
Cannabis craving and cross-substance substitution during cannabis treatment: Initial insights across seven cannabis use disorder clinical trials.
Article in Addictive behaviors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundCannabis cessation or reduction may increase cross-substance substitution in response to craving or reduced use. Evidence for substitution is mixed, and treatment effects remain unclear. This exploratory study examined alcohol and tobacco substitution within clinical trials of cannabis cessation.
designData were pooled from 829 participants (Mage = 27.1, SD = 9.1; 31 % female; 63 % White; 13 % Latine/Hispanic) across seven pharmacologic cannabis use disorder (CUD) trials. Weekly cannabis, alcohol, and cigarette use were assessed (cigarettes in six trials). Longitudinal mixed-effects models tested whether cannabis use or craving predicted next-week alcohol and cigarette outcomes, with treatment condition included as a moderator.
resultsNo significant three-way interactions with treatment emerged. Cannabis craving interacted with cannabis frequency to predict modest increases in next-week alcohol quantity (b = 0.009, p = 0.04970497), although not drinking frequency. Higher cannabis quantity predicted lower next-week cigarette quantity (b = - 0.009, p = 0.042). There was limited evidence of a treatment × craving interaction for cigarette frequency (b = - 0.008, p = 0.04990499), with higher craving associated with fewer smoking days in the active treatment arm.
conclusionsAlcohol findings were consistent with complementary use patterns, whereas cigarette smoking showed evidence of both concurrent coco-use and prospective substitution with cannabis. Pharmacotherapy did not broadly alter these relationships; however, among participants receiving active treatment, greater cannabis craving was associated with fewer smoking days. These findings provide initial evidence supporting monitoring of polysubstance use during CUD treatment and consideration of how cessation efforts may differentially affect alcohol and tobacco use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.